Identification of a Lysosomal Peptide Transport System Induced during Dendritic Cell Development*
暂无分享,去创建一个
R. Tampé | P. Brossart | A. Hasilik | Z. Waibler | U. Kalinke | S. Appel | F. Grünebach | R. Abele | O. Demirel
[1] Peter Cresswell,et al. Exposure of the Promonocytic Cell Line THP-1 to Escherichia coli Induces IFN-γ-Inducible Lysosomal Thiol Reductase Expression by Inflammatory Cytokines1 , 2006, The Journal of Immunology.
[2] K. Rock,et al. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. , 2006, Current opinion in immunology.
[3] Ronald E. Bontrop,et al. Immunogenetics , 2005, Genes and Immunity.
[4] Peter Cresswell,et al. Mechanisms of MHC class I‐restricted antigen processing and cross‐presentation , 2005, Immunological reviews.
[5] J. C. Wolters,et al. Selective and ATP-dependent Translocation of Peptides by the Homodimeric ATP Binding Cassette Transporter TAP-like (ABCB9)* , 2005, Journal of Biological Chemistry.
[6] H. Baker,et al. Differential maturation of murine bone-marrow derived dendritic cells with lipopolysaccharide and tumor necrosis factor-alpha. , 2005, Journal of endotoxin research.
[7] Delu Zhou,et al. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. , 2005, Immunity.
[8] Jonathan D Wren,et al. Differential activation profiles of multiple transcription factors during dendritic cell maturation. , 2005, The Journal of investigative dermatology.
[9] S. Ostrand-Rosenberg,et al. Presentation of Endogenously Synthesized MHC Class II-Restricted Epitopes by MHC Class II Cancer Vaccines Is Independent of Transporter Associated with Ag Processing and the Proteasome1 , 2005, The Journal of Immunology.
[10] J. Auwerx,et al. The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiation , 1991, Experientia.
[11] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[12] I. Mellman. Antigen processing and presentation by dendritic cells: cell biological mechanisms. , 2005, Advances in experimental medicine and biology.
[13] J. Dice,et al. Mechanisms of chaperone-mediated autophagy. , 2004, The international journal of biochemistry & cell biology.
[14] M. Maeda,et al. Membrane localization of transporter associated with antigen processing (TAP)-like (ABCB9) visualized in vivo with a fluorescence protein-fusion technique. , 2004, Biological & pharmaceutical bulletin.
[15] S. Michnick,et al. Detection of TAP family dimerizations by an in vivo assay in mammalian cells. , 2004, Biochemistry.
[16] S. Mayor,et al. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment , 2004, Journal of Cell Science.
[17] Robert Tampé,et al. The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. , 2004, Physiology.
[18] J. Villadangos,et al. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. , 2004, Blood.
[19] R. Tampé,et al. Functional Dissection of the Transmembrane Domains of the Transporter Associated with Antigen Processing (TAP)* , 2004, Journal of Biological Chemistry.
[20] Kaan E. Biron,et al. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain , 2003, Nature Immunology.
[21] R. Tampé,et al. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Maeda,et al. Gene organization of human transporter associated with antigen processing-like (TAPL, ABCB9): analysis of alternative splicing variants and promoter activity. , 2003, Biochemical and biophysical research communications.
[23] J. Davoust,et al. ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells , 2003, Nature.
[24] Etienne Gagnon,et al. Phagosomes are competent organelles for antigen cross-presentation , 2003, Nature.
[25] J. Klein,et al. Identification and characterization of a TAP-family gene in the lamprey , 2003, Immunogenetics.
[26] R. Tampé,et al. Functional cysteine‐less subunits of the transporter associated with antigen processing (TAP1 and TAP2) by de novo gene assembly , 2003, FEBS letters.
[27] P. Brossart,et al. Activated CD8+ T lymphocytes induce differentiation of monocytes to dendritic cells and restore the stimulatory capacity of interleukin 10-treated antigen-presenting cells. , 2002, Cancer research.
[28] Joshua M. Korn,et al. The plasticity of dendritic cell responses to pathogens and their components. , 2001, Science.
[29] L. Kanz,et al. The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. , 2001, Cancer research.
[30] Francesca Granucci,et al. Transcriptional reprogramming of dendritic cells by differentiation stimuli , 2001, European journal of immunology.
[31] J. Yewdell,et al. Multiple Antigen-Specific Processing Pathways for Activating Naive CD8+ T Cells In Vivo , 2001, The Journal of Immunology.
[32] R. Tampé,et al. Allosteric crosstalk between peptide-binding, transport, and ATP hydrolysis of the ABC transporter TAP , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] A. Davidson,et al. Vanadate-Induced Trapping of Nucleotides by Purified Maltose Transport Complex Requires ATP Hydrolysis , 2000, Journal of bacteriology.
[34] P. Hwu,et al. Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen‐specific T lymphocytes , 2000, European journal of immunology.
[35] T. Fujiwara,et al. A half-type ABC transporter TAPL is highly conserved between rodent and man, and the human gene is not responsive to interferon-gamma in contrast to TAP1 and TAP2. , 2000, Journal of biochemistry.
[36] L. Kanz,et al. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. , 2000, Cancer research.
[37] V. Ling,et al. Characterization of ABCB9, an ATP Binding Cassette Protein Associated with Lysosomes* , 2000, The Journal of Biological Chemistry.
[38] J. Elliott,et al. Cytoplasmic Processing Is a Prerequisite for Presentation of an Endogenous Antigen by Major Histocompatibility Complex Class II Proteins , 2000, The Journal of experimental medicine.
[39] M. Saraste,et al. FEBS Lett , 2000 .
[40] Y. Yamaguchi,et al. An ABC transporter homologous to TAP proteins , 1999, FEBS letters.
[41] S. Rosenberg,et al. Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen. , 1999, Science.
[42] A. Plebani,et al. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. , 1999, The Journal of clinical investigation.
[43] M. Androlewicz,et al. Herpes Simplex Virus Inhibitor ICP47 Destabilizes the Transporter Associated with Antigen Processing (TAP) Heterodimer* , 1998, The Journal of Biological Chemistry.
[44] A. Enk,et al. Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions , 1997, European journal of immunology.
[45] J. Yewdell,et al. Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[46] V. Verhasselt,et al. Interleukin‐10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin‐4 and granulocyte/ macrophage‐colony‐stimulating factor , 1997, European journal of immunology.
[47] J. Pieters. MHC class II restricted antigen presentation. , 1997, Current opinion in immunology.
[48] R. Naviaux,et al. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses , 1996, Journal of virology.
[49] J. Neefjes,et al. Translocation of long peptides by transporters associated with antigen processing (TAP) , 1996, European journal of immunology.
[50] S. Tonegawa,et al. TAP1‐independent loading of class I molecules by exogenous viral proteins , 1995, European journal of immunology.
[51] J. Salamero,et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. , 1994, Science.
[52] J. Yewdell,et al. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide. , 1994, Journal of immunology.
[53] William Arbuthnot Sir Lane,et al. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.
[54] C. Higgins,et al. ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.
[55] Eric O Long,et al. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells , 1992, Nature.
[56] J. Slot,et al. Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi , 1992, Nature.
[57] V. Hořejší,et al. Stimulation of the biosynthesis of lactosamine repeats in glycoproteins in differentiating U937 cells and its suppression in the presence of NH4Cl. , 1992, European journal of cell biology.
[58] J. Strominger,et al. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[59] A. Rudensky,et al. Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.
[60] P. Cresswell,et al. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I- restricted cell-mediated lysis , 1991, The Journal of experimental medicine.
[61] Eric O Long,et al. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells , 1990, The Journal of experimental medicine.
[62] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[63] Eric O Long,et al. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells , 1989, Journal of virology.